253 related articles for article (PubMed ID: 30104344)
1. S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.
Liu C; Zhang CW; Lo SQ; Ang ST; Chew KCM; Yu D; Chai BH; Tan B; Tsang F; Tai YK; Tan BWQ; Liang MC; Tan HT; Tang JY; Lai MKP; Chua JJE; Chung MCM; Khanna S; Lim KL; Soong TW
J Neurosci; 2018 Sep; 38(39):8364-8377. PubMed ID: 30104344
[TBL] [Abstract][Full Text] [Related]
2. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1.
Jia W; Xu H; Du X; Jiang H; Xie J
Neurobiol Aging; 2015 Feb; 36(2):1183-93. PubMed ID: 25467637
[TBL] [Abstract][Full Text] [Related]
3. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
4. The S-nitrosylation of parkin attenuated the ubiquitination of divalent metal transporter 1 in MPP
Zhong Y; Li X; Du X; Bi M; Ma F; Xie J; Jiang H
Sci Rep; 2020 Sep; 10(1):15542. PubMed ID: 32968192
[TBL] [Abstract][Full Text] [Related]
5. Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levels.
Howitt J; Gysbers AM; Ayton S; Carew-Jones F; Putz U; Finkelstein DI; Halliday GM; Tan SS
PLoS One; 2014; 9(1):e87119. PubMed ID: 24475238
[TBL] [Abstract][Full Text] [Related]
6. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.
Zhang S; Wang J; Song N; Xie J; Jiang H
Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 Mediates Inflammation-Induced DMT1 Increase and Dopaminergic Neurodegeneration in the Early Stage of Parkinsonism.
Liang T; Yang SX; Qian C; Du LD; Qian ZM; Yung WH; Ke Y
Mol Neurobiol; 2024 Apr; 61(4):2006-2020. PubMed ID: 37833459
[TBL] [Abstract][Full Text] [Related]
9. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.
Salazar J; Mena N; Hunot S; Prigent A; Alvarez-Fischer D; Arredondo M; Duyckaerts C; Sazdovitch V; Zhao L; Garrick LM; Nuñez MT; Garrick MD; Raisman-Vozari R; Hirsch EC
Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18578-83. PubMed ID: 19011085
[TBL] [Abstract][Full Text] [Related]
10. [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice].
Jiang H; Qian ZM; Xie JX
Sheng Li Xue Bao; 2003 Oct; 55(5):571-6. PubMed ID: 14566406
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.
Ayton S; Lei P; Hare DJ; Duce JA; George JL; Adlard PA; McLean C; Rogers JT; Cherny RA; Finkelstein DI; Bush AI
J Neurosci; 2015 Feb; 35(8):3591-7. PubMed ID: 25716857
[TBL] [Abstract][Full Text] [Related]
12. Transgenic Mice Overexpressing the Divalent Metal Transporter 1 Exhibit Iron Accumulation and Enhanced Parkin Expression in the Brain.
Zhang CW; Tai YK; Chai BH; Chew KCM; Ang ET; Tsang F; Tan BWQ; Hong ETE; Asad ABA; Chuang KH; Lim KL; Soong TW
Neuromolecular Med; 2017 Sep; 19(2-3):375-386. PubMed ID: 28695462
[TBL] [Abstract][Full Text] [Related]
13. Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease.
Chew KC; Ang ET; Tai YK; Tsang F; Lo SQ; Ong E; Ong WY; Shen HM; Lim KL; Dawson VL; Dawson TM; Soong TW
J Biol Chem; 2011 Sep; 286(38):33380-9. PubMed ID: 21795716
[TBL] [Abstract][Full Text] [Related]
14. Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx.
Song N; Jiang H; Wang J; Xie JX
J Neurosci Res; 2007 Nov; 85(14):3118-26. PubMed ID: 17663481
[TBL] [Abstract][Full Text] [Related]
15. Effects of intracerebroventricular injection of iron dextran on the iron concentration and divalent metal transporter 1 expression in the caudate putamen and substantia nigra of rats.
Yu P; Chang YZ; Miao W; Wang SM; Cui R; Qian ZM; Ke Y; Duan XL
Anat Rec (Hoboken); 2009 Feb; 292(2):225-33. PubMed ID: 19051252
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
17. Regulation of divalent metal transporter-1 by serine phosphorylation.
Seo YA; Kumara R; Wetli H; Wessling-Resnick M
Biochem J; 2016 Nov; 473(22):4243-4254. PubMed ID: 27681840
[TBL] [Abstract][Full Text] [Related]
18. Distribution of divalent metal transporter-1 in the monkey basal ganglia.
Huang E; Ong WY; Connor JR
Neuroscience; 2004; 128(3):487-96. PubMed ID: 15381278
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1.
Cheah JH; Kim SF; Hester LD; Clancy KW; Patterson SE; Papadopoulos V; Snyder SH
Neuron; 2006 Aug; 51(4):431-40. PubMed ID: 16908409
[TBL] [Abstract][Full Text] [Related]
20. A role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese.
Wolff NA; Garrick MD; Zhao L; Garrick LM; Ghio AJ; Thévenod F
Sci Rep; 2018 Jan; 8(1):211. PubMed ID: 29317744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
